Cutaneous plasmacytosis (CP) is an uncommon chronic disease of unknown aetiology, reported mainly in middle-aged patients of Asian descent. It is diagnosed by a constellation of physical, laboratory, radiological and histopathological findings. We report a patient with CP who demonstrated a favorable and promising response to mask-bath PUVA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajd.12360 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cutaneous Plasmacytosis: A Rare Dermatological Condition Mimicking Systemic Plasma Cell Disorders.
Cureus
December 2024
Dermatology, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Cutaneous plasmacytosis (CP) is a rare condition characterized by benign proliferation of mature plasma cells in the skin. It presents as reddish-brown macules, papules, or plaques, typically located on the neck, face, and trunk. The etiology remains unknown, though it is believed to be reactive rather than malignant.
View Article and Find Full Text PDFDifferences in safety profiles of anti-herpesvirus medications: a real-world pharmacovigilance study based on the FAERS database.
Expert Opin Drug Saf
October 2024
Department of Pharmacy, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Article Synopsis
- The study compared the safety profiles of four anti-herpesvirus drugs—acyclovir, ganciclovir, valaciclovir, and foscarnet—using data from the FDA Adverse Event Reporting System from 2004 to 2023.
- All drugs showed significant risks for hematotoxicity, with ganciclovir and foscarnet being the most myelosuppressive.
- Specific associations were noted: foscarnet posed the highest risk for renal impairment and seizures, while acyclovir had strong ties to neurotoxicity and severe skin reactions.
IgG4-related disease developing during the course of cutaneous plasmacytosis.
Eur J Dermatol
August 2024
Department of Dermatology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Widespread purplish-red plaques with plasma cell infiltrate: A rare type of lichen planus.
J Cutan Pathol
December 2024
Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Article Synopsis
- Rare skin diseases with plasma cell infiltration can transition from benign to malignant, featuring presentations like purplish or reddish-brown plaques and nodules.
- A unique case of lichen planus showed typical histopathological features but involved unusual plasma cells with restricted light chain expression.
- Patients should be monitored for changes in their rash, and clinicians may need to perform repeated biopsies and multisystem evaluations to track the disease's progression.
Cutaneous plasmacytosis treated with tocilizumab.
Clin Exp Dermatol
November 2024
Division of Dermatology, University of Louisville School of Medicine, Louisville, KY, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!